Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
0Diseases
| Target & Modality | |||
|---|---|---|---|
Menstrual blood-derived mesenchymal stem cells (MenSCs)No recent activity | Phase 1/2 | Mesenchymal stem cell / Tissue regenerationCell therapy | Indication not yet linked |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.